QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 evercore-isi-group-maintains-outperform-on-iqvia-hldgs-lowers-price-target-to-250

Evercore ISI Group analyst Elizabeth Anderson maintains IQVIA Hldgs (NYSE:IQV) with a Outperform and lowers the price target...

 truist-securities-maintains-buy-on-iqvia-hldgs-lowers-price-target-to-292

Truist Securities analyst Jailendra Singh maintains IQVIA Hldgs (NYSE:IQV) with a Buy and lowers the price target from $297 ...

 baird-maintains-neutral-on-iqvia-hldgs-lowers-price-target-to-245

Baird analyst Eric Coldwell maintains IQVIA Hldgs (NYSE:IQV) with a Neutral and lowers the price target from $254 to $245.

 iqvia-lowers-fy24-outlook-revenue-15325b---15575b-down-from-1540b---1560b-vs-1553b-estimate-reaffirm-adj-eps-outlook-1095---1125-vs-111-estimate

Full-Year 2024 Guidance The company reaffirms its full-year revenue guidance on a constant currency basis. After adjusting fo...

 iqvia-hldgs-q1-2024-adj-eps-254-beats-248-estimate-sales-3737b-beat-3699b-estimate

IQVIA Hldgs (NYSE:IQV) reported quarterly earnings of $2.54 per share which beat the analyst consensus estimate of $2.48 by 2.4...

 salesforce--iqvia-expand-partnership-life-sciences-cloud-gets-a-superpower-boost

Salesforce shares rise after partnership with IQVIA to develop Life Sciences Cloud for customer engagement.

Core News & Articles

IQVIA (NYSE:IQV), a leading global provider of data, analytics, technology and services to the life sciences industry, and Sale...

 truist-securities-maintains-buy-on-iqvia-hldgs-raises-price-target-to-297

Truist Securities analyst Jailendra Singh maintains IQVIA Hldgs (NYSE:IQV) with a Buy and raises the price target from $286 ...

 leerink-partners-initiates-coverage-on-iqvia-hldgs-with-outperform-rating-announces-price-target-of-290

Leerink Partners analyst Michael Cherny initiates coverage on IQVIA Hldgs (NYSE:IQV) with a Outperform rating and announces ...

 guggenheim-downgrades-iqvia-hldgs-to-neutral

Guggenheim analyst Sandy Draper downgrades IQVIA Hldgs (NYSE:IQV) from Buy to Neutral.

 stocks-rebound-as-investor-focus-shifts-to-earnings-bitcoin-tops-1-trillion-value-whats-driving-markets-wednesday

The U.S. stock market attempted a rebound following Tuesday’s declines, which were sparked by a higher-than-expected inflation ...

 healthcare-analytics-focused-iqvia-says-2023-performance-solid-despite-challenging-macro-environment

IQVIA beats Q4 2023 sales expectations, reporting $3.87 billion (3.5% Y/Y). Adjusted EPS of $2.84 exceeds guidance. IQV's 2...

 charles-river-laboratories-international-posts-upbeat-results-joins-robinhood-zillow-tower-semiconductor-and-other-big-stocks-moving-higher-on-wednesday

U.S. stocks were higher, with the Dow Jones index gaining more than 100 points on Wednesday.

 iqvia-hldgs-q4-adjusted-eps-284-beats-282-estimate-sales-387b-beat-379b-estimate

IQVIA Hldgs (NYSE:IQV) reported quarterly earnings of $2.84 per share which beat the analyst consensus estimate of $2.82 by 0.7...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION